Concepedia

Fu Xiong

FX

Statistics

Publications

5

Citations

167

H-Index

5

Active since

2009

Affiliations

Huazhong University of Science and Technology(Current)

Union Hospital

Peking University

Fu Xiong is an author at Huazhong University of Science and Technology specializing in radiation oncology, cancer research, and medicine.

ORCID

Top concepts

Publications per year

2009–2022

5

Publications

5

LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma

Hua Yang, Fu Xiong, Ming Lin et al. · Journal of Cancer Research and Clinical Oncology · 2009 · 62 citations · Full text

, , +11

Safety and efficacy of lenvatinib combined with camrelizumab plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A two-center retrospective study

Bo Sun, Lijie Zhang, Tao Sun et al. · Frontiers in Oncology · 2022 · 39 citations · Full text

Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma

Yusheng Guo, Yanqiao Ren, Lei Chen et al. · BMC Cancer · 2022 · 38 citations · Full text

Non–Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia–enhanced Herpes Simplex Virus Thymidine Kinase Gene Therapy

Jiansong Ji, Qiaoyou Weng, Feng Zhang et al. · Radiology · 2018 · 18 citations · Full text

, , +16

Reduced expression of ASS is closely related to clinicopathological features and post-resectional survival of hepatocellular carcinoma

Hua Yang, Ming Lin, Fu Xiong et al. · Oncology Letters · 2009 · 10 citations · Full text

1–5 of 5